238 related articles for article (PubMed ID: 11149418)
21. SCAP ligands are potent new lipid-lowering drugs.
Grand-Perret T; Bouillot A; Perrot A; Commans S; Walker M; Issandou M
Nat Med; 2001 Dec; 7(12):1332-8. PubMed ID: 11726974
[TBL] [Abstract][Full Text] [Related]
22. Cytokine regulation of low-density lipoprotein receptor gene transcription in human mesangial cells.
Ruan XZ; Varghese Z; Fernando R; Moorhead JF
Nephrol Dial Transplant; 1998 Jun; 13(6):1391-7. PubMed ID: 9641167
[TBL] [Abstract][Full Text] [Related]
23. microRNA-185 modulates low density lipoprotein receptor expression as a key posttranscriptional regulator.
Jiang H; Zhang J; Du Y; Jia X; Yang F; Si S; Wang L; Hong B
Atherosclerosis; 2015 Dec; 243(2):523-32. PubMed ID: 26523989
[TBL] [Abstract][Full Text] [Related]
24. Synergistic activation of human LDL receptor expression by SCAP ligand and cytokine oncostatin M.
Liu J; Zhang F; Li C; Lin M; Briggs MR
Arterioscler Thromb Vasc Biol; 2003 Jan; 23(1):90-6. PubMed ID: 12524230
[TBL] [Abstract][Full Text] [Related]
25. Sirolimus modifies cholesterol homeostasis in hepatic cells: a potential molecular mechanism for sirolimus-associated dyslipidemia.
Ma KL; Ruan XZ; Powis SH; Chen Y; Moorhead JF; Varghese Z
Transplantation; 2007 Oct; 84(8):1029-36. PubMed ID: 17989609
[TBL] [Abstract][Full Text] [Related]
26. Inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase unmask transcriptional regulation of hepatic low-density lipoprotein receptor gene expression by dietary cholesterol.
Lopez D; Ness GC
Arch Biochem Biophys; 1997 Aug; 344(1):215-9. PubMed ID: 9244400
[TBL] [Abstract][Full Text] [Related]
27. Domains of transcription factor Sp1 required for synergistic activation with sterol regulatory element binding protein 1 of low density lipoprotein receptor promoter.
Yieh L; Sanchez HB; Osborne TF
Proc Natl Acad Sci U S A; 1995 Jun; 92(13):6102-6. PubMed ID: 7597088
[TBL] [Abstract][Full Text] [Related]
28. Nerve growth factor (NGF) and pro-NGF increase low-density lipoprotein (LDL) receptors in neuronal cells partly by different mechanisms: role of LDL in neurite outgrowth.
Do HT; Bruelle C; Pham DD; Jauhiainen M; Eriksson O; Korhonen LT; Lindholm D
J Neurochem; 2016 Jan; 136(2):306-15. PubMed ID: 26484803
[TBL] [Abstract][Full Text] [Related]
29. Activation of peroxisome proliferator-activated receptor-alpha in mice induces expression of the hepatic low-density lipoprotein receptor.
Huang Z; Zhou X; Nicholson AC; Gotto AM; Hajjar DP; Han J
Br J Pharmacol; 2008 Oct; 155(4):596-605. PubMed ID: 18852694
[TBL] [Abstract][Full Text] [Related]
30. A novel peroxisome proliferator response element modulates hepatic low-density lipoprotein receptor gene transcription in response to PPARδ activation.
Shende VR; Singh AB; Liu J
Biochem J; 2015 Dec; 472(3):275-86. PubMed ID: 26443862
[TBL] [Abstract][Full Text] [Related]
31. Modulation of ERG25 expression by LDL in vascular cells.
Rodriguez C; Raposo B; Martínez-González J; Llorente-Cortés V; Vilahur G; Badimon L
Cardiovasc Res; 2003 Apr; 58(1):178-85. PubMed ID: 12667960
[TBL] [Abstract][Full Text] [Related]
32. The steroidal analog GW707 activates the SREBP pathway through disruption of intracellular cholesterol trafficking.
Zhang J; Dudley-Rucker N; Crowley JR; Lopez-Perez E; Issandou M; Schaffer JE; Ory DS
J Lipid Res; 2004 Feb; 45(2):223-31. PubMed ID: 14617742
[TBL] [Abstract][Full Text] [Related]
33. Hepatic overexpression of idol increases circulating protein convertase subtilisin/kexin type 9 in mice and hamsters via dual mechanisms: sterol regulatory element-binding protein 2 and low-density lipoprotein receptor-dependent pathways.
Sasaki M; Terao Y; Ayaori M; Uto-Kondo H; Iizuka M; Yogo M; Hagisawa K; Takiguchi S; Yakushiji E; Nakaya K; Ogura M; Komatsu T; Ikewaki K
Arterioscler Thromb Vasc Biol; 2014 Jun; 34(6):1171-8. PubMed ID: 24675665
[TBL] [Abstract][Full Text] [Related]
34. Polyphenol-rich black chokeberry (Aronia melanocarpa) extract regulates the expression of genes critical for intestinal cholesterol flux in Caco-2 cells.
Kim B; Park Y; Wegner CJ; Bolling BW; Lee J
J Nutr Biochem; 2013 Sep; 24(9):1564-70. PubMed ID: 23517916
[TBL] [Abstract][Full Text] [Related]
35. Identification of a novel sterol-independent regulatory element in the human low density lipoprotein receptor promoter.
Liu J; Ahlborn TE; Briggs MR; Kraemer FB
J Biol Chem; 2000 Feb; 275(7):5214-21. PubMed ID: 10671569
[TBL] [Abstract][Full Text] [Related]
36. Human ATP-binding cassette transporter-2 (ABCA2) positively regulates low-density lipoprotein receptor expression and negatively regulates cholesterol esterification in Chinese hamster ovary cells.
Davis W; Boyd JT; Ile KE; Tew KD
Biochim Biophys Acta; 2004 Jul; 1683(1-3):89-100. PubMed ID: 15238223
[TBL] [Abstract][Full Text] [Related]
37. Androgens stimulate lipogenic gene expression in prostate cancer cells by activation of the sterol regulatory element-binding protein cleavage activating protein/sterol regulatory element-binding protein pathway.
Heemers H; Maes B; Foufelle F; Heyns W; Verhoeven G; Swinnen JV
Mol Endocrinol; 2001 Oct; 15(10):1817-28. PubMed ID: 11579213
[TBL] [Abstract][Full Text] [Related]
38. Conditional response of the human steroidogenic acute regulatory protein gene promoter to sterol regulatory element binding protein-1a.
Christenson LK; Osborne TF; McAllister JM; Strauss JF
Endocrinology; 2001 Jan; 142(1):28-36. PubMed ID: 11145563
[TBL] [Abstract][Full Text] [Related]
39. Disruption of LDL receptor gene in transgenic SREBP-1a mice unmasks hyperlipidemia resulting from production of lipid-rich VLDL.
Horton JD; Shimano H; Hamilton RL; Brown MS; Goldstein JL
J Clin Invest; 1999 Apr; 103(7):1067-76. PubMed ID: 10194480
[TBL] [Abstract][Full Text] [Related]
40. The physiological role of sterol regulatory element-binding protein-2 in cultured human cells.
Kawabe Y; Suzuki T; Hayashi M; Hamakubo T; Sato R; Kodama T
Biochim Biophys Acta; 1999 Jan; 1436(3):307-18. PubMed ID: 9989262
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
